Article Sidebar
Views PDF: 17
EVALUATION OF OVARIAN STIMULATION USING AN ANTAGONIST PROTOCOL WITH DELTA FOLLITROPIN IN WOMEN UNDERGOING IN VITRO FERTILIZATION
Main Article Content
Abstract
Objective: To evaluate the clinical outcomes of ovarian stimulation using an antagonist protocol with Follitropin Delta in women undergoing in vitro fertilization (IVF). Materials and Methods: This cross-sectional descriptive study included 120 infertile patients who underwent ovarian stimulation with Follitropin Delta for IVF. Outcomes assessed included the number of follicles on ultrasound, number of follicles retrieved, number of mature oocytes, fertilization rate, and the number of embryos obtained on Day 3 and Day 5. Results: The mean duration of ovarian stimulation was 10.76 ± 1.52 days. The mean total dose of Delta Follitropin administered was 145.25 ± 23.63 µg. The mean number of oocytes retrieved was 16.82 ± 7.85, with a high fertilization rate of 89%. The mean number of Day-3 embryos was 6.83 ± 5.34, while the mean number of Day-5 embryos was 4.62 ± 3.75. The mean number of good-quality Day-5 blastocysts was 3.55 ± 3.31. Conclusion: Ovarian stimulation using the antagonist protocol with Delta Follitropin demonstrated favorable outcomes, with a high number of oocytes retrieved and satisfactory embryo development on both Day 3 and Day 5. These findings suggest that Delta Follitropin is an effective option for controlled ovarian stimulation in IVF cycles.
Article Details
Keywords
ovarian stimulation, Delta Follitropin
References
2. R Orvieto, R Nahum, J Rabinson, J Ashkenazi, EY Anteby, S Meltcer. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: Is there any difference? Fertil Steril. 2009; 91(4):1522-1525.
3. Monica Lispi, Peter Humaidan, George R Bousfield, Thomas D'Hooghe, Alfredo Ulloa-Aguirre. Follicle-stimulating hormone biological products: Does potency predict clinical efficacy? International Journal of Molecular Sciences. 2023; 24.
4. S Komiya, J Watanabe, T Terayama, K Kamijo, H Okada. Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta-analysis. Reprod Med Biol. 2024; 23(1):e12573.
5. S Palomba, D Caserta, PE Levi- Setti, A Busnelli. Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/intracytoplasmic sperm injection cycles: A systematic review with meta-analysis. J Ovarian Res. 2024; 17(1):60.
6. P. Devroey, R. Boostanfar, N. P. Koper et al. A double- blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol, Hum Reprod. 2009 Dec; 24(12): 3063–3072.
7. Yan J, Wu K, Tang R, Ding L, Chen ZJ. Efect of maternal age on the outcomes of in vitro fertilization and embryo tranfer (IVF-ET), Sci China Life Sci. 2012 Aug; 55(8): 694- 8.
8. Vũ Văn Tâm, Vũ Thị Minh Phương. Hiệu quả kích thích buồng trứng của Folitropin Delta trên các bệnh nhân làm TTTON tại Bệnh viện Phụ sản Hải Phòng. 2023.
9. J. Havelock, A.-K. Aaris Henningsen, B. Mannaerts, J.-C. Arce, ESTHER-1, and E.-T. Groups. Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta. Journal of Assisted Reproduction and Genetics, vol. 38, pp. 2651-2661
10. E. Bosch, J. Havelock, F. S. Martin et al. Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial. Reproductive BioMedicine Online. 2019, vol. 38, no. 2, pp. 195-205.
11. Sesh Kamal Sunkara, Vivian Rittenberg, Nick Raine- Fenning et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400.135 treatment cycles. Human Reprod. 2011, Vol.0, No.0: pp 1 – 7.
12. Witmyer J. Derivation of embryonic stem – cell lines from human blastocysts, NenglJ Med, 2004 Mar 25; 350(13): 1353-6.
13. Jonh F. Payne, Douglas J. Raburn, Grace M. Couchman et al. Relationship between pre-embryo pronuclear morphology (Zygote score) and standard day 2 or 3 embryo morphology with regard to assisted reproductive technique outcome, Fertility and Sterility. 2005, 84(4), 900-909.